Major Pharm & Biotech Firms Concealing Nature of their Research For U.S. Gov't

[Hissyspit]

http://www.afterdowningstreet.org/?q=node/23878

U.S. Corporations Aren’t Disclosing Biological Warfare Research Work
Submitted by davidswanson on Fri, 2007-06-22 16:51. Media
By Sherwood Ross

A number of major pharmaceutical corporations and biotech firms are concealing the nature of the biological warfare research work they are doing for the U.S. government.

Since their funding comes from the National Institutes of Health, the recipients are obligated under NIH guidelines to make their activities public. Not disclosing their ops raises the suspicion they may be engaged in forbidden kinds of germ warfare research.

According to the Sunshine Project, a nonprofit arms control watchdog operating out of Austin, Texas, among corporations holding back information about their activities are:
Abbott Laboratories, BASF Plant Science, Bristol-Myers Squibb, DuPont Central Research and Development, Eli Lilly Corp., Embrex, GlaxoSmithKline, Hoffman-LaRoche, Merck & Co., Monsanto, Pfizer Inc., Schering-Plough Research Institute, and Syngenta Corp. of Switzerland.

In case you didn’t know it, the White House since 9/11 has called for spending $44-billion on biological warfare research, a sum unprecedented in world history, and an obliging Congress has authorized it.
Thus, some of the deadliest pathogens known to humankind are being rekindled in hundreds of labs in pharmaceutical houses, university biology departments, and on military bases.
An international convention the U.S. signed forbids it to stockpile, manufacture or use biological weapons. But if the U.S. won’t say what’s going down in those laboratories other countries are going to assume the worst and a biowarfare arms race will be on, if it isn’t already.
Sunshine says failure to disclose operations also puts corporate employees involved in this work at risk. Only 8,500, or 16%, of the 52,000 workers employed at the top 20 U.S. biotech firms work at an NIH guidelines-compliant company, Sunshine says.
Francis Boyle, an international law authority at the University of Illinois, Champaign, says pursuant to national strategy directives adopted by Bush in 2002, the Pentagon “is now gearing up to fight and ‘win’ biological warfare without prior public knowledge and review.” Boyle said the Pentagon’s Chemical and Biological Defense Program was revised in 2003 to endorse “first-use” strike in war. Boyle said the program includes Red Teaming, which he described as “plotting, planning, and scheming how to use biowarfare.”

Besides the big pharmaceutical houses, the biowarfare buildup is getting an enthusiastic response from academia, which sees new funds flowing from Washington’s horn of plenty. “American universities have a long history of willingly permitting their research agenda, researchers, institutes and laboratories to be co-opted, corrupted, and perverted by the Pentagon and the CIA,” Boyle says.

MORE

[sicksicksick_N_tired]

1. O!M!G!

:scared: "plotting, planning, and scheming how to use biowarfare"?!?!?!!!!! ON WHOM?
EEEK!!!!

[acmavm]

2. The Stand by Stephen King popped into my mind.

Of course they're doing nasty things. These are nasty people.

[irislake]

3. What a wonderful wonderful country

is the U.S. of A. It is a joy and a pleasure to share the planet with a country with such high ideals. Is this how you pursue "happiness"? Thanks a helluva lot for this!

[GeorgeGist]

4. Just out of curiosity ...

I searched the CRISP database ( http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen) at NIH and found no record of any NIH funding of Abbott Laboratories. I also checked the Sunshine Project website and the only references to Abbott Laboratories was in regard to their failure to provide evidence that they have a Institutional Biosafety Commitee AND this statement:

The US does not have comprehensive laboratory safety law, thus, the IBCs operate under non-binding
guidelines managed by the US National Institutes of Health.

http://www.sunshine-project.org/biodefense/tspibc.pdf